Abstract:Abstract: Objective To investigate effect of leukotriene B4 (LTB4) and eotaxin (CCL11) in exhaled breath condensate (EBC) on the evaluation of asthma in children. Methods Sixty-four children with asthma were enrolled, including 33 with acute asthma exacerbation, 18 with chronic asthma and 13 with asthma remission; and 8 healthy children were enrolled as controls. The EBC of each subject was collected using R-Tube. LTB4 and CCL11 were detected by ELISA in each sample. Results The LTB4 levels of EBC in the order from high to low were the acute asthma exacerbation group [(70.89 ± 8.31) pg/ml], the chronic asthma group [(35.27 ± 6.61) pg/ml], the asthma remission group [(24.58 ± 4.90 pg/ml)], and the control group [(15.53 ± 3.24 pg/ml)]; there were significant differences among the groups (P < 0.05). The CCL11 level of EBC was the highest in the acute asthma exacerbation group [(3.38 ± 0.65) pg/ml], followed by the chronic asthma group [(2.46 ± 0.52) pg/ml], the asthma remission group [(0.90 ± 0.36) pg/ml], and the control group [(0.71 ± 0.26) pg/ml]; there was no significant difference between the asthma remission group and the control group (P > 0.05). Conclusions The levels of LTB4 and CCL11 in EBC can reflect the status of airway inflammation in asthma and its control. They are valuable in assessment of the condition of children with asthma.